ADMA BIOLOGICS INC - C

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

05 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces CFO Transition

28 фев 2024 16:10:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

28 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire

ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

21 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics

21 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update

08 янв 2024 07:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management

18 дек 2023 16:05:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older

12 дек 2023 07:00:00 Источник Nasdaq GlobeNewswire

ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD

16 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update

08 ноя 2023 16:05:01 Источник Nasdaq GlobeNewswire

ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023

01 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update

09 авг 2023 16:05:01 Источник Nasdaq GlobeNewswire

ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023

02 авг 2023 07:00:02 Источник Nasdaq GlobeNewswire

ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA

19 июл 2023 07:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update

10 май 2023 16:05:01 Источник Nasdaq GlobeNewswire

ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023

03 май 2023 07:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Amendment to Credit Agreement

02 май 2023 07:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

23 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire

ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023

16 мар 2023 07:00:01 Источник Nasdaq GlobeNewswire

ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA

08 фев 2023 07:00:00 Источник Nasdaq GlobeNewswire